16 February 2016
3rd SCOR Young European Researcher Prize for research into Alzheimer’s disease
The 3rd SCOR Young European Researcher Prize, financed by the SCOR Corporate Foundation for Science, was awarded to Dr Lawrence Rajendran of the University of Zurich. Lawrence Rajendran’s remarkable work notably deals with the genes that predispose people to develop Alzheimer’s disease. For neurodegenerative diseases it is often impossible to isolate one responsible gene, which was previously the case for Alzheimer’s disease. However, the emergence of functional genomics methods and computational tools has led to advances in the understanding of the complex molecular networks underlying the disease.
Lawrence Rajendran’s work also deals with the link between food and the development of neurodegenerative diseases. Consuming too much protein, which is found for example in red meat, incites the brain to use this source of energy instead of consuming the proteins present in its own cells. This overconsumption encourages an accumulation of abnormal proteins in the brain’s cells. These amyloid proteins formed in the brain play a role in the development of Alzheimer’s disease. Aside from nutritional recommendations, Lawrence Rajendran’s work opens the way to possible medical developments, with the use of medication that encourages the brain to refuse this external source of protein and focus instead on its own resources.
The SCOR Corporate Foundation for Science is proud to support the Alzheimer’s Research Foundation for the third consecutive year through this SCOR Young European Researcher Prize. Extending and reinforcing a partnership initiated by SCOR in 2008, the SCOR Corporate Foundation for Science teamed up with the research programme of the Alzheimer’s Research Foundation, signing a sponsorship agreement on 12 June 2013 that commits the SCOR Corporate Foundation for Science to the payment of EUR 1 million over five years. As well as creating an annual award for young European researchers, the agreement notably enables the Research Foundation to continue to observe a cohort of patients as part of a long-term study of Alzheimer’s sufferers, and to promote cooperation with foreign scientists in the field of research into this disease.
30 April 2015
The SCOR FOUNDATION SEMINAR ON CLIMATE RISKS will be held on 9 and 10 June 2015 in Paris
In the context of the 21st Session of the Conference of the Parties to the United Nations Framework Convention on Climate Change (COP21/CMP11) taking place in November/December 2015 in Paris, the SCOR Foundation for Science will take place on 9 and 10 June at SCOR, 5 avenue Kléber, Paris.
This event, organized in conjunction with The Geneva Association and the Toulouse School of Economics, will bring together numerous experts and academics, and will be held exclusively in English.
The full program is available on the event website http://scor-climaterisks-2015.com.
14 October 2014
The 2014 Nobel Prize in Economic Sciences is awarded to Jean Tirole, member of the SCOR Corporate Foundation for Science
On 13 October 2014, the Royal Swedish Academy of Science honoured Jean Tirole for his work on the functioning and regulation of markets. Following in the footsteps of Gérard Debreu in 1983 and Maurice Allais in 1988, Jean Tirole is the third Frenchman to receive the prestigious Nobel Prize in Economic Sciences.
SCOR is particularly pleased about this distinction awarded to Jean Tirole, who is chairman of the JJ Laffont Foundation - Toulouse School of Economics, with which SCOR is proud to have worked in the context of two research chairs: “Market Risk and Value Creation” since 2008 and “Finance” since 2009.
These chairs have enabled Jean Tirole and the researchers at TSE to conduct outstanding theoretical and empirical research into risk, which may be consulted on the SCOR website and has given rise to numerous publications in the best international academic journals. This collaboration gives SCOR real-time access to the most recent academic risk research results, and furthers “the art and science of risk” constituting its comparative advantage.
At the beginning of the 1990s, Jean-Jacques Laffont sought the assistance of Denis Kessler, then Chairman of the FFSA (Fédération Française des Sociétés d’Assurance), to create the Toulouse School of Economics, with the aim of attracting researchers working in Anglo-Saxon universities. In this context, the FFSA awarded a research Chair to Jean-Jacques Laffont in 1992, thereby enabling him to found the Toulouse School of Economics, which Jean Tirole joined at around this time.
Jean Tirole has been a member of the Scientific Board of the SCOR Corporate Foundation for Science since its creation in 2012. The SCOR Foundation aims to support research and the diffusion of scientific knowledge on the themes of risk and insurance.
A brilliant theoretician, Jean Tirole is one of the ten most quoted economists in global economic research. His works deal with an extremely wide variety of economic areas (market organisation, financial regulation, risk, agent behaviour, the labour market and economic policy). He has published a very large number of scientific articles in the most prestigious international academic reviews.
Denis Kessler, Chairman & CEO of SCOR, comments: “I would like to join the scientific and economic community in warmly applauding this prize, which congratulates a very great, rigorous and influential economist.”
12 June 2013
The SCOR Corporate Foundation for Science
supports research into Alzheimer’s disease
Extending and reinforcing a collaborative relationship begun by SCOR 5 years ago, the SCOR Corporate Foundation for Science has become involved in the research programme led by the Alzheimer’s Research Foundation in France. This sponsorship agreement, signed on 12 June 2013, commits the SCOR Corporate Foundation for Science to the payment of EUR 1 million over the next five years. As well as creating an annual award for young European researchers, the agreement will notably enable the Research Foundation to continue to observe a cohort of patients as part of a long-term study of Alzheimer’s sufferers, and to promote cooperation with foreign scientists in the field of research into this disease.
The SCOR Corporate Foundation for Science, the launch of which was announced on 20 December 2012, receives annual support from SCOR to finance new projects. Its aims are as follows: (i) to promote and finance research in terms of knowledge, management and insurability for all topics relating to risk; (ii) to promote and finance initial and vocational training in scientific fields, particularly with regard to finance and insurance, both in France and abroad; (iii) to promote and finance technical cooperation outside France, in the fields of research, scientific knowledge, and particularly insurance and finance.
The aim of the Alzheimer’s Research Foundation is to support and coordinate research into Alzheimer’s disease and related disorders. It has notably provided financial support to a research project whose principal aim is to constitute a clinical database, including a brain bank, as part of the longitudinal study of patients with Alzheimer’s disease or related disorders. The resulting standardised information and samples are now available to international research teams. The Foundation also supports the Memory and Alzheimer’s Disease Institute, which opened in 2010 at the Pitié-Salpêtrière hospital in Paris. Under the supervision of Professor Bruno Dubois, this clinical centre puts patients at the heart of researchand enables them to benefit from the latest innovations in terms of prevention, diagnosis, care and therapy. The Foundation has also become a member of the Board of Directors of IHU-A-ACM, a university hospital institute dealing with nervous system diseases at the Pitié-Salpêtrière hospital. This institute was named by an international jury as a centre of excellence in 2011.
André Lévy-Lang, chairman of the SCOR Corporate Foundation for Science, comments: “With this project, the first it has financed since it was created, the SCOR Corporate Foundation for Science is delighted to contribute to research into Alzheimer’s disease. This multi-year commitment will enable the Alzheimer’s Research Foundation to continue its long-term study of Alzheimer’s patients under the best possible conditions”.
Link to the website of the Alzheimer’s Research Foundation